<DOC>
	<DOCNO>NCT01983306</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy range oral SP-333 dos treatment opioid-induced constipation ( OIC ) adults non-cancer pain take opioids .</brief_summary>
	<brief_title>Dose-ranging Study Assess Safety Efficacy SP-333 Treatment Opioid-induced Constipation ( OIC )</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<criteria>Must receive chronic , stable opioid therapy treat nonmalignant pain least 3 month prior screen Must active OIC screen Active OIC must confirm baseline screen bowel habit symptom diary Must stable diet Has history chronic therapy chronic constipation prior start opioid therapy , potential nonopioid cause bowel dysfunction may major contributor constipation ( i.e. , mechanical obstruction pseudoobstruction ) Use medication might affect bowel movement frequency constipationrelated symptom ( e.g. , prokinetics , antidiarrheal agent , laxative studydefined rescue laxative ) Has history current cancer ( basal cell squamous cell carcinoma skin ) unless malignancy complete remission without maintenance chemotherapy least 5 year Unstable thyroid disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Constipation</keyword>
	<keyword>Opioid</keyword>
	<keyword>GC C Agonist</keyword>
	<keyword>Pain</keyword>
</DOC>